CDC Study Says Sinus Infections Are Treated With Antibiotics Longer Than Necessary - AJMC.com Managed Markets Network

A CDC study published in JAMA Internal Medicine on Monday found that primary care providers are prescribing antibiotics for sinus infections longer than recommended by clinical practice guidelines. A key antibiotic stewardship principle is to use the shortest effective length of antibiotics recommended by guidelines in order to fight the growing problem of antibiotic resistance.

A CDC study published in JAMA Internal Medicine on Monday found that primary care providers are prescribing antibiotics for sinus infections longer than recommended by clinical practice guidelines.

A key antibiotic stewardship principle is to use the shortest effective length of antibiotics recommended by guidelines in order to fight the growing problem of antibiotic resistance. In the report, the CDC said that antibiotic stewardship programs can ensure that treatment adheres to these guidelines.

According to the CDC, at least 2 million people become infected with bacteria that are resistant to antibiotics each year. Additionally, at least 23,000 people die as a direct result of these infections, and many more die from other conditions that were complicated by an antibiotic-resistant infection. Last year, The Joint Commission put in place an antimicrobial stewardship standard for institutions to follow.

Antibiotics are prescribed more for sinus infections than for any other illness. The CDC study focused on an estimated 3.7 million visits (95% CI, 3,124,279-4,269,673) at which antibiotic therapy was prescribed for sinusitis that met the study criteria. More than two-thirds (69.6%) of antibiotic prescriptions, and 91.5% of non-azithromycin antibiotic prescriptions, were for 10 days or longer, even though the Infectious Diseases Society of America recommends 5 to 7 days of therapy for uncomplicated cases of sinusitis.

In addition, more than 20% of antibiotic prescriptions for sinus infections were for 5 days of azithromycin, even though guidelines recommend against prescribing azithromycin because of high rates of existing resistance to this drug and others in its class.

No penicillin or tetracycline prescriptions were for 5-day courses, and only 5% of antibiotic prescriptions were for 7-day courses of penicillins, tetracyclines, or fluoroquinolones.

According to the authors, although 7- to 10-day courses are recommended for patients at high risk or whose initial treatment has failed, it is unlikely that such cases represent the majority of patients captured in the study. They cited previous work that has shown that shorter durations (3-7 days) of antibiotics have been associated with similar outcomes and fewer drug-related adverse events compared with longer durations (6-10 days).

The study has limitations, the authors said. They were not able to account for underlying conditions or other indicators that may have called for a longer course of antibiotics. Because visits with a diagnosis of unspecified sinusitis were excluded from the analysis, some cases of acute sinusitis may have been missed. However, the findings of a sensitivity analysis that included cases of both acute and unspecified sinusitis were similar.

Reference

King LM, Sanchez GV, Bartoces M, Hicks LA, Fleming-Dutra KE. Antibiotic therapy duration in US adults with sinusitis [published online March 26, 2018]. JAMA Intern Med. doi: 10.1001/jamainternmed.2018.0407.

Adblock test (Why?)

Comments

Post a Comment

Popular posts from this blog

Rashes that look like scabies: Causes, symptoms, and treatment - Medical News Today

Image
Scabies is a skin condition that occurs as the result of a mite known as Sarcoptes scabiei. The rash that results from scabies may appear similar to other skin conditions, such as psoriasis, eczema, or contact dermatitis. In this article, we look at what a scabies rash looks like. We also look at other rashes that are similar in appearance and their treatment options. Scabies is a common condition that occurs as the result of an infestation of a microscopic skin mite called Sarcoptes scabiei. The mites burrow under the skin, causing intense itching and a rash. The Centers for Disease Control and Prevention (CDC) describes the rash as pimple-like. On darker skin, the rash may be more difficult to see, but a person should be able to feel it. According to DermNet, a scabies rash is varied in appearance, and may appear as: pimple-like on the limbs and trunk widespread or coin-shaped small blisters scales lesions in the armpits, groin, navel, areolas, scrotum, buttocks, and along the penil...
Read more

Urinary Tract Infection (UTI): Causes, Symptoms & Treatment - Cleveland Clinic

Image
Can I prevent a urinary tract infection? The following lifestyle changes can help prevent urinary tract infections: Practice good hygiene Practicing good hygiene is one of the best ways to help prevent UTIs. This is especially important if you have a vagina because your urethra is much shorter, and it's easier for E. coli to move from your rectum back into your body. Always wipe from front to back after a bowel movement (pooping) to avoid this. During your menstrual cycle, it's also a good idea to regularly change your period products, including pads and tampons. You should also avoid using any deodorants on your vagina. Drink plenty of fluids Drinking extra fluids — especially water — each day can help flush out bacteria from your urinary tract. Healthcare providers recommend drinking six to eight glasses of water daily. Change your peeing habits Peeing can play a big role in getting rid of bacteria from your body. Your pee is a waste product, and each time you empty your bla...
Read more

Symtuza: Uses, side effects, alternatives, and more - Medical News Today

Image
The Food and Drug Administration (FDA) approves prescription drugs such as Symtuza to treat certain conditions. Symtuza is FDA-approved to treat HIV-1 in adults and children who weigh at least 40 kilograms (kg), which is about 88 pounds (lb). It's approved for people who: have just been diagnosed with HIV and haven't started treatment yet, OR are changing from another HIV treatment and: have been on a stable antiretroviral regimen for at least 6 months (this means you haven't had any changes to your HIV drugs for at least 6 months) have a viral load (the amount of HIV in your blood) that's less than 50 copies per milliliter (mL) have HIV that doesn't have mutations (changes) that could make it resistant (less likely to respond) to darunavir or tenofovir (two of the active drugs in Symtuza) HIV explained HIV stands for human immunodeficiency virus. There are two forms of this virus, HIV-1 and HIV-2. HIV-1 is the most common form. HIV is transmitted through body fluid...
Read more